Pharmacogenomics Market Revenue, Forecast, Overview and Key Companies Analysis by 2028
The global Pharmacogenomics Market is expected to reach USD 11.97 Billion by 2027, according to a new report by Emergen Research. The global pharmacogenomics (PGx) market is growing at a substantial pace owing to the growing demand for personalized therapy, increasing prevalence of target chronic diseases, technological advancements, favorable government initiatives, availability of financial support for research and development.
The report provides detailed insights into Pharmacogenomics market revenue trends, industry trends, consumer trends, market size, market share, market revenue growth drivers, and forecast, along with ranging impact of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in Pharmacogenomics market size over the forecast period, 2020–2028. The report includes profiles of major players in the Pharmacogenomics market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.
Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/88
Global Pharmacogenomics market revenue growth is primarily driven by a variety of factors and trends, some of which include rising focus by major companies on product/service expansion into new and untapped domestic and international markets, rising investments in strategic agreements and mergers, and rapidly growing competition in the Pharmacogenomics market.
Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the Pharmacogenomics market. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is expected to drive Pharmacogenomics market revenue growth to a significant extent over the forecast period.
Top key vendors in Pharmacogenomics Market include are:
- Key participants include Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd, geneOmbio Technologies Pvt Ltd., Genomic Health, Inc., Illumina, Inc., and Laboratory Corporation of America Holdings, among others.
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
For the purpose of this report, Emergen Research has segmented into the global Pharmacogenomics Market on the basis of products and services, technology, application, end-use, and region:
- Product and Services Outlook (Revenue, USD Billion; 2017-2027)
- Assays and Reagents
- SNP Identification
- Pharmacogenetic Testing
- Other Services
- Technology Outlook (Revenue, USD Billion; 2017-2027)
- Polymerase Chain Reaction (PCR)
- Real-Time PCR
- Digital PCR
- DNA Sequencing/Next Generation Sequencing (NGS)
- Nucleic Acid Amplification Tests (NAATs)
- Mass Spectrometry
- Gel Electrophoresis
- Fluorescence In Situ Hybridization (FISH)
- Chromogenic In Situ Hybridization (CISH)
- Application Outlook (Revenue, USD Billion; 2017-2027)
- Infectious Diseases
- End-Use Outlook (Revenue, USD Billion; 2017-2027)
- Research Organization
- Pharmaceutical Companies
- Diagnostic Centers
Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@ https://www.emergenresearch.com/industry-report/pharmacogenomics-market
Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Pharmacogenomics Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2020 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.
Region wise performance of the Pharmacogenomics industry
North America Pharmacogenomics market revenue growth was relatively higher than that of other regional markets in 2020. North America market revenue is expected to continue to remain dominant over the forecast period, supported majorly by robust presence of major players in countries in the region and expansion of overall economic Pharmacogenomics growth strategies and initiatives.
Asia Pacific Pharmacogenomics market revenue registered the fastest growth rate in 2020, and this trend is expected to continue over the forecast period. Asia Pacific Pharmacogenomics market revenue growth is driven by significant market revenue contribution from China, India, and South Korea. Increasing population, favorable government policies and initiatives, and availability of more advanced technologies, services, and offerings in these countries are some key factors driving Pharmacogenomics market revenue growth in Asia Pacific.
Europe Pharmacogenomics market revenue is expected to continue to remain steady over the forecast period. This can be attributed to changing Pharmacogenomics market trends in countries in other major regions and robust focus on research and development initiatives by major firms in the region with the objective to leverage opportunities and drive Pharmacogenomics revenue growth.
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:
- United States
- Southeast Asia
We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
We can customize our reports for our customers, for instance, we can add or remove manufacturers, applications or product types, whatever you need in the report. Ask for it by contacting us@ https://www.emergenresearch.com/request-for-customization/88
The research provides answers to the following key questions:
- What will be the growth rate and the market size of the Pharmacogenomics industry for the forecast period 2020-2027?
- What are the major driving forces expected to impact the development of the Pharmacogenomics market across different regions?
- Who are the major driving forces expected to decide the fate of the Pharmacogenomics industry worldwide?
- Who are the prominent market players making a mark in the Pharmacogenomics market with their winning strategies?
- Which Pharmacogenomics industry trends are likely to shape the future of the industry during the forecast period 2020-2027?
- What are the key barriers and threats believed to hinder the development of the industry?
- What are the future opportunities in the Pharmacogenomics market?
Table of Content
Chapter 1. Methodology & Sources
1.1. Pharmacogenomics Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.3. Paid Sources
1.5. Pharmacogenomics Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2021-2028
Chapter 3. Key Insights
Chapter 4. Pharmacogenomics Market Segmentation & Impact Analysis
4.1. Pharmacogenomics Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Pharmacogenomics Market indicators analysis
4.2.2. Pharmacogenomics Market drivers analysis
126.96.36.199. Rapid urbanization and industrialization
188.8.131.52. Stringent government regulations regarding carbon emissions
184.108.40.206. Increasing prevalence of respiratory diseases
220.127.116.11. Rising need to enhance indoor air quality
4.2.3. Pharmacogenomics Market restraints analysis
18.104.22.168. High cost associated with the maintenance of Pharmacogenomics products
22.214.171.124. Availability of renewable sources of energy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 10. Competitive Landscape
10.1. Pharmacogenomics Market Revenue Share By Manufacturers
10.2. Mergers & Acquisitions
10.3. Competitor’s Positioning
10.4. Strategy Benchmarking
10.5. Vendor Landscape
10.5.1. Raw Material Suppliers
10.5.1.1. North America
10.5.1.3. Asia Pacific
10.5.1.4. Middle East & Africa
10.5.1.5. Latin America
10.5.2.1. North America
10.5.2.3. Asia Pacific
10.5.2.4. Middle East & Africa
10.5.2.5. Latin America
Avail Discount on Pharmacogenomics Market Report@ https://www.emergenresearch.com/request-discount/88
Why Choose Emergen Research?
- Strong Industry Focus
- Extensive Product Offerings
- Customer Research Services
- Robust Research Methodology
- Comprehensive Reports
- Latest Technological Developments
- Value Chain Analysis
- Potential Market Opportunities
- Growth Dynamics
- Quality Assurance
- Post-sales Support